Evidence map›Paper›PMID 41699055›Full record

ArticleNPJ digital medicine2026

Bridging radiology and pathology: domain-generalized cross-modal learning for clinical.

Xiang Zhong, Zhuo Gu, Manimurugan Shanmuganathan, Meng Li, Hao Sun, Mingming Du, Qian Chen, Guoqin Jiang

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiang ZhongDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Zhuo GuDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Manimurugan ShanmuganathanUniversity of Tabuk, Faculty of Computers and Information Technology, Tabuk, Kingdom of Saudi Arabia.
Meng LiSchool of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei, Anhui, China.
Hao SunWolfson Institute for Biomedical Research, UCL, University College London, London, London, UK. Haosun2021@163.com.
Mingming DuCAS Key Laboratory of Nano-Bio Interface, Division of Nanobiomedicine and i-Lab, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, Jiangsu, China. mmdu2016@sinano.ac.cn.
Qian ChenMedical Science and Technology Innovation Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical University, Suzhou, Jiangsu, China. qc2020@mail.ustc.edu.cn.
Guoqin JiangDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. jiang_guoqin@163.com.

Funding

Nanjing Medical University Gusu School Youth Talent Development Program Grant No. GSKY20250523Natural Science Foundation of Jiangsu Province BK20250383Postgraduate Research & Practice Innovation Program of Jiangsu Province SJCX25_1793Suzhou Gusu talent plan for Health Technical Personnel project GSWS2021024
6 · The paper itself

Abstract

Reliable interpretation of clinical imaging requires integrating complementary evidence across modalities, yet most AI systems remain limited by single-modality analysis and poor generalization across institutions. We propose a unified cross-modal framework that bridges mammography and histopathology for breast cancer diagnosis through: (1) a shared vision transformer encoder with lightweight modality-specific adapters, (2) a weakly supervised patient-level contrastive alignment module that learns cross-modal correspondences without pixel-level supervision, (3) domain generalization strategies combining MixStyle augmentation and invariant risk minimization, and (4) causal test-time adaptation for unseen target domains. The model jointly addresses classification, lesion localization, and pathological grading while generating reasoning-guided attention maps that explicitly link suspicious mammographic regions with corresponding histopathological evidence. Evaluated on four public benchmarks (CBIS-DDSM, INbreast, BACH, CAMELYON16/17), the framework consistently outperforms state-of-the-art unimodal, multimodal, and domain generalization baselines, achieving mean AUC of 0.90 under rigorous leave-one-domain-out evaluation and substantially smaller domain gaps (0.03 vs. 0.06-0.10). Visualization and interpretability analyses further confirm that predictions align with clinically meaningful features, supporting transparency and trust. By advancing multimodal integration, cross-institutional robustness, and explainability, this study represents a step toward clinically deployable AI systems for diagnostic decision support.

Identifiers

PMID41699055
PMCPMC13022417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.